Methodological issues in primary prevention trials for neurodegenerative dementia

Area of Science:

• Neuroscience
• Public Health
• Gerontology

Background:

• Neurodegenerative dementias, including Alzheimer's disease, pose a significant public health challenge.
• Early intervention to delay disease onset could yield substantial public health benefits.
• Randomized controlled trials (RCTs) are essential for validating preventive strategies but present unique methodological challenges in this field.

Purpose of the Study:

• To identify and review primary prevention randomized controlled trials (RCTs) for neurodegenerative dementia.
• To summarize and discuss the methodologies employed in these RCTs.
• To highlight challenges and suggest improvements for future prevention trials.

Main Methods:

• A comprehensive literature search was conducted to find primary prevention RCTs for neurodegenerative dementia.
• The methodologies of identified trials were systematically summarized.
• Expert meetings were held to discuss the findings and methodological issues.

Main Results:

• A total of 39 RCTs were identified, evaluating dementia incidence or cognitive decline.
• Participant selection commonly used age as a criterion.
• Follow-up durations varied significantly, from one month to nine years, with longer periods for dementia incidence studies.
• Observed trial results have been largely negative and inconsistent with observational studies, potentially due to methodological limitations.

Conclusions:

• Current RCTs for dementia prevention face methodological hurdles, including target population selection, outcome measurement, and trial duration.
• Attrition in long-term studies is a significant concern that requires careful assessment.
• Future RCTs need refined methodologies to accurately evaluate the efficacy of preventive interventions for neurodegenerative dementias.